Novitium Pharma LLC et al v. Xeris Pharmaceuticals, Inc. et al
| Novitium Pharma LLC and ANI Pharmaceuticals, Inc. |
| Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited |
| 1:2026cv01044 |
| August 17, 2026 |
| U.S. District Court for the District of Delaware |
| Other Statutory Actions |
| 28 U.S.C. ยง 1331 Fed. Question |
| None |
Docket Report
This docket was last retrieved on August 18, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 4 Summons Issued as to Strongbridge Dublin Limited on 8/18/2026; Xeris Pharmaceuticals, Inc. on 8/18/2026. (Attachments: #1 Summons Issued)(oam) |
| Filing 3 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent ANI Pharmaceuticals, Inc., Other Affiliate BlackRock, Inc. for Novitium Pharma LLC; Other Affiliate BlackRock, Inc. for ANI Pharmaceuticals, Inc. filed by ANI Pharmaceuticals, Inc., Novitium Pharma LLC. (oam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 1 COMPLAINT against Strongbridge Dublin Limited, Xeris Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-5043962) - filed by ANI Pharmaceuticals, Inc., Novitium Pharma LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet)(oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.